mr DAVID WARR

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

HR 4/ S 3: Medicare Prescription Drug Price Negotiation Act of 2007. Lobbied to maintain the private sector negotiations in the Medicare drug benefit. HR 2058/S.1103: Helping Fill the Medicare Rx Gap Act. Lobbied to enhance patient access to Medicare Part D drugs. H.R.1293/S. 1338-Access to Medicare Imaging Act of 2007. Lobbied for passage of bills. HR 1845/S 1428 Medicare Durable Medical Equipment Access Act. Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care. Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System. Lobbied to ensure patient access to ostomy services.

HR 976: Small Business Tax Relief Act. Lobbied to support favorable provisions of the tax code. HR 1712: R&D Tax Credit. Lobbied to make permanent the tax credit.

HR 4/ S 3: Medicare Prescription Drug Price Negotiation Act of 2007. Lobbied to maintain the private sector negotiations in the Medicare drug benefit. HR 2058/S.1103: Helping Fill the Medicare Rx Gap Act. Lobbied to enhance patient access to Medicare Part D drugs. H.R.1293/S. 1338-Access to Medicare Imaging Act of 2007. Lobbied for passage of bills. HR 1845/S 1428 Medicare Durable Medical Equipment Access Act. Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care. Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System. Lobbied to ensure patient access to ostomy services.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

Panama, Columbia, and Peru Free Trade Agreements. Lobbied to ensure fair patent protections in trade agreements. HR 1908/S 1145: Patent Reform Act. Lobbied to ensure fair patent protections for pharmaceuticals.

H.R. 1908/S. 1145, Patent Reform Act, Lobbied to ensure fair patent protections for pharmaceuticals.

H.R. 1908/S. 1145, Patent Reform Act, Lobbied to ensure fair patent protections for pharmaceuticals.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

HR 4/ S 3: Medicare Prescription Drug Price Negotiation Act of 2007. Lobbied to maintain the private sector negotiations in the Medicare drug benefit. HR 2058/S.1103: Helping Fill the Medicare Rx Gap Act. Lobbied to enhance patient access to Medicare Part D drugs. H.R.1293/S. 1338-Access to Medicare Imaging Act of 2007. Lobbied for passage of bills. HR 1845/S 1428 Medicare Durable Medical Equipment Access Act. Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care. Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System. Lobbied to ensure patient access to ostomy services.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

H.R.3966 Tax Increase Prevention Act of 2007, Lobbied to achieve an extension of the Research and Development Tax Audit.

H.R.3966 Tax Increase Prevention Act of 2007, Lobbied to achieve an extension of the Research and Development Tax Audit.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

HR 4/ S 3: Medicare Prescription Drug Price Negotiation Act of 2007. Lobbied to maintain the private sector negotiations in the Medicare drug benefit. HR 2058/S.1103: Helping Fill the Medicare Rx Gap Act. Lobbied to enhance patient access to Medicare Part D drugs. H.R.1293/S. 1338-Access to Medicare Imaging Act of 2007. Lobbied for passage of bills. HR 1845/S 1428 Medicare Durable Medical Equipment Access Act. Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care. Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System. Lobbied to ensure patient access to ostomy services.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

HR 4/ S 3: Medicare Prescription Drug Price Negotiation Act of 2007. Lobbied to maintain the private sector negotiations in the Medicare drug benefit. HR 2058/S.1103: Helping Fill the Medicare Rx Gap Act. Lobbied to enhance patient access to Medicare Part D drugs. H.R.1293/S. 1338-Access to Medicare Imaging Act of 2007. Lobbied for passage of bills. HR 1845/S 1428 Medicare Durable Medical Equipment Access Act. Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care. Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System. Lobbied to ensure patient access to ostomy services.

H.R. 1908/S. 1145, Patent Reform Act, Lobbied to ensure fair patent protections for pharmaceuticals.

H.R. 1908/S. 1145, Patent Reform Act, Lobbied to ensure fair patent protections for pharmaceuticals.

Panama, Columbia, and Peru Free Trade Agreements. Lobbied to ensure fair patent protections in trade agreements. HR 1908/S 1145: Patent Reform Act. Lobbied to ensure fair patent protections for pharmaceuticals.

HR 4/ S 3: Medicare Prescription Drug Price Negotiation Act of 2007. Lobbied to maintain the private sector negotiations in the Medicare drug benefit. HR 2058/S.1103: Helping Fill the Medicare Rx Gap Act. Lobbied to enhance patient access to Medicare Part D drugs. H.R.1293/S. 1338-Access to Medicare Imaging Act of 2007. Lobbied for passage of bills. HR 1845/S 1428 Medicare Durable Medical Equipment Access Act. Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care. Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System. Lobbied to ensure patient access to ostomy services.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

HR 4/ S 3: Medicare Prescription Drug Price Negotiation Act of 2007. Lobbied to maintain the private sector negotiations in the Medicare drug benefit. HR 2058/S.1103: Helping Fill the Medicare Rx Gap Act. Lobbied to enhance patient access to Medicare Part D drugs. H.R.1293/S. 1338-Access to Medicare Imaging Act of 2007. Lobbied for passage of bills. HR 1845/S 1428 Medicare Durable Medical Equipment Access Act. Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care. Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System. Lobbied to ensure patient access to ostomy services.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

S. Con. Res. 21, Establishing the Congressional budget for the U.S. Government for FY 2008 and including the appropriate budgetary levels for FY 2007 and 2009-2012, Lobbied to ensure safety and access to prescription drugs. S. 1751, An original bill making appropriations for energy and water development for the fiscal year ending September 30, 2008, and for other purposes, Lobbied to restore $25 million in funding for nuclear medicine research. H.R. 2764, Omnibus Appropriations Bill, Lobbied to maintain safety and access to prescription drugs. H.R. 1591/S. 965, Supplemental Appropriations bill, Lobbied to maintain the current Medicaid rebate percentage.

S. Con. Res. 21- Establishing the Congressional budget for the U.S. Government for FY 2008 and including the appropriate budgetary levels for FY 2007 and 2009-2012. Lobbied to ensure safety and access to prescription drugs. S.1751: An original bill making appropriations for energy and water development for the fiscal year ending September 30, 2008, and for other purposes. Lobbied to restore $25 million in funding for nuclear medicine research. HR 1591/ S 965: Supplemental Appropriations bill. Lobbied to maintain the current Medicaid rebate percentage.

H.R. 2419, Farm Bill Extension Act of 2007, Lobbied for inclusion of more fruits and vegetables in school lunch program. S. 2302, The Food and Energy Security Act of 2007, Lobbied for inclusion of more fruits and vegetables in school lunch program.

H.R. 2419, Farm Bill Extension Act of 2007, Lobbied for inclusion of more fruits and vegetables in school lunch program. S. 2302, The Food and Energy Security Act of 2007, Lobbied for inclusion of more fruits and vegetables in school lunch program.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

HR 4/ S 3: Medicare Prescription Drug Price Negotiation Act of 2007. Lobbied to maintain the private sector negotiations in the Medicare drug benefit. HR 2058/S.1103: Helping Fill the Medicare Rx Gap Act. Lobbied to enhance patient access to Medicare Part D drugs. H.R.1293/S. 1338-Access to Medicare Imaging Act of 2007. Lobbied for passage of bills. HR 1845/S 1428 Medicare Durable Medical Equipment Access Act. Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care. Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System. Lobbied to ensure patient access to ostomy services.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit. H.R. 3963, SCHIP Extension Bill,Lobbied to maintain safety and access to prescription drugs. H.R.1293/S. 1338, Access to Medicare Imaging Act of 2007, Lobbied for passage of bills. H.R. 2058/S. 1103, Helping Fill the Medicare Rx Gap Act, Lobbied to enhance patient access to Medicare Part D drugs H.R. 1845/S. 1428, Medicare Durable Medical Equipment Access Act, Lobbied to ensure patient access to Medicare durable medical equipment - ostomy and wound care services. Medicare Coverage Policy for Wound Care, Lobbied to ensure patient access to timely and appropriate treatment options. Home Health Prospective Payment System, Lobbied to ensure patient access to ostomy services. Medicaid Rebate Policy, Lobbied to ensure proper payment of rebates.

H.R. 4/ S. 3, Medicare Prescription Drug Price Negotiation Act of 2007, Lobbied to maintain private sector negotiations in the Medicare drug benefit.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

S. Con. Res. 21- Establishing the Congressional budget for the U.S. Government for FY 2008 and including the appropriate budgetary levels for FY 2007 and 2009-2012. Lobbied to ensure safety and access to prescription drugs. S.1751: An original bill making appropriations for energy and water development for the fiscal year ending September 30, 2008, and for other purposes. Lobbied to restore $25 million in funding for nuclear medicine research. HR 1591/ S 965: Supplemental Appropriations bill. Lobbied to maintain the current Medicaid rebate percentage.

S. Con. Res. 21, Establishing the Congressional budget for the U.S. Government for FY 2008 and including the appropriate budgetary levels for FY 2007 and 2009-2012, Lobbied to ensure safety and access to prescription drugs. S. 1751, An original bill making appropriations for energy and water development for the fiscal year ending September 30, 2008, and for other purposes, Lobbied to restore $25 million in funding for nuclear medicine research. H.R. 2764, Omnibus Appropriations Bill, Lobbied to maintain safety and access to prescription drugs. H.R. 1591/S. 965, Supplemental Appropriations bill, Lobbied to maintain the current Medicaid rebate percentage.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900/ S 1082:Food and Drug Administration Amendments. Lobbied for adequate funding for FDA and related issues. H.R.2589: Improving Pharmaceuticals for Children Act. Lobbied for passage of bill. HR 1038/ HR 1956/S 623/ S 1659: To create a pathway for FDA to approve follow-on biologic drugs. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S 1710: Labor, HHS Appropriations bill. Lobbied to ensure patient access to HIV drugs through the ADAP program. HR 380/S 242:Pharmaceutical Market Access and Drug Safety Act. Lobbied to protect patient safety of prescription drugs. S 1342: Healthy Lifestyles and Prevention America Act. 'HeLP America Act'. Lobbied for inclusion of more fruits and vegetables in school lunch program. HR 2144: Farm, Nutrition, and Community Investment Act of 2007. Lobbied for inclusion of more fruits and vegetables in school lunch program. H. Res. 433/ S. Res 221: Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month. Lobbied for passage of resolutions. H.R.583/S.1042: Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007. Lobbied for passage of bills.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

H.R. 2900, Food and Drug Administration Amendments, Lobbied for adequate funding for FDA and related issues. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H. Res. 433, Supporting the goals and ideals of National Peripheral Arterial Disease Awareness Month, Lobbied for passage of resolution. S. Res. 221, A resolution supporting National Peripheral Arterial Disease Awareness Month and efforts to educate people about peripheral arterial disease, Lobbied for passage of resolution. H.R. 583/S. 1042, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007, Lobbied for passage of bills. H.R. 380/S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, Lobbied to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes, to ensure safety of drugs and access for patients. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1038/S. 623, Access to Life-Saving Medicine Act,Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S.1505, Affordable Biologics for Consumers Act, Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act, Lobbied for passage of bill. H.R. 2589, Improving Pharmaceuticals for Children Act, Lobbied for passage of bill. S. 1082, Prescription Drug User Fee Amendments of 2007, Lobbied for adequate funding for FDA and related issues. H.R. 3610, Food and Drug Import Safety Act of 2007, Lobbied to ensure safety and access to prescription drugs. H.R. 1585, Defense Authorization Bill, Lobbied to maintain safety and access to prescription drugs. S. 1710, Labor, HHS Appropriations bill, Lobbied to ensure patient access to HIV drugs through the ADAP program.

S. Con. Res. 21, Establishing the Congressional budget for the U.S. Government for FY 2008 and including the appropriate budgetary levels for FY 2007 and 2009-2012, Lobbied to ensure safety and access to prescription drugs. S. 1751, An original bill making appropriations for energy and water development for the fiscal year ending September 30, 2008, and for other purposes, Lobbied to restore $25 million in funding for nuclear medicine research. H.R. 2764, Omnibus Appropriations Bill, Lobbied to maintain safety and access to prescription drugs. H.R. 1591/S. 965, Supplemental Appropriations bill, Lobbied to maintain the current Medicaid rebate percentage.

S. Con. Res. 21- Establishing the Congressional budget for the U.S. Government for FY 2008 and including the appropriate budgetary levels for FY 2007 and 2009-2012. Lobbied to ensure safety and access to prescription drugs. S.1751: An original bill making appropriations for energy and water development for the fiscal year ending September 30, 2008, and for other purposes. Lobbied to restore $25 million in funding for nuclear medicine research. HR 1591/ S 965: Supplemental Appropriations bill. Lobbied to maintain the current Medicaid rebate percentage.

HR.2419: The Farm, Nutrition, and Bioenergy Act. Lobbied for inclusion of more fruits and vegetables in school lunch program. Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for the fiscal year ending September 30, 2008, and for other purposes. Lobbied for inclusion of more fruits and vegetables in school lunch program.

S. Con. Res. 21, Establishing the Congressional budget for the U.S. Government for FY 2008 and including the appropriate budgetary levels for FY 2007 and 2009-2012, Lobbied to ensure safety and access to prescription drugs. S. 1751, An original bill making appropriations for energy and water development for the fiscal year ending September 30, 2008, and for other purposes, Lobbied to restore $25 million in funding for nuclear medicine research. H.R. 2764, Omnibus Appropriations Bill, Lobbied to maintain safety and access to prescription drugs. H.R. 1591/S. 965, Supplemental Appropriations bill, Lobbied to maintain the current Medicaid rebate percentage.

HR 976: Small Business Tax Relief Act. Lobbied to support favorable provisions of the tax code. HR 1712: R&D Tax Credit. Lobbied to make permanent the tax credit.

Lobbied to prevent provisions adverse to prescription drug approval process.H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870, Federal Food, Drug and Cosmetic Act, Lobbied to ensure safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R.4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R.3559, Medicare DME Access Act, Lobbied to ensure access to medical devices and DME services. H.R. 6143, Ryan White Care Act Reauthorization, Lobbied to ensure safe access to prescription drugs. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.2300, Lower Priced Drugs Act of 2006, Lobbied to preserve incentives for R&D for pediatric populations. S.3558, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. S.3650, Helping Fill the Medicare Rx Gap Act, Lobbied to ensure safe access to prescription drugs. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children. S.Res 556, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Res 982, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005.

H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005. Lobbied to prevent provisions adverse to prescription drug approval process. H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870,Federal Food, Drug and Cosmetic Act , Lobbied to ensure the safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R. 4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R. 3559, Medicare DME Access Act, Lobbied to remove certain DME services from competitive bidding, implement quality standards, and passage of the bill. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.3558, The National Hepatitis B Awareness Act of 2006, lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit bran name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children.

H.R.563, Prescription Drug Affordability Act of 2005, Lobbied to prevent passage of the bill. Lobbied to remove federally imposed cap on Puerto Rico for Medicaid funding. H.R.4939, Emergency Supplemental Appropriations Act of Defense, the Global War on Terror, and Hurricane Recovery, 2006, Lobbied to preserve the market based Medicare Part D Rx drug benefit.H.Con.Res.373, Establishing the congressional budget for the United States Government for fiscal year 2007, Lobbied to preserve the Medicare Part D drug benefit. H.R.376, Medicare's Equitable Drugs for Seniors Act of 2005, Lobbied against signing a discharge petition to bring this bill to a floor vote.

H.R.376, Medicare's Equitable Drugs for Seniors Act of 2005, Lobbied again signing a discharge petition to bring this bill to a floor vote. H.R.563, Prescription Drug Affordability Act of 2005, Lobbied to prevent passage of the bill. Lobbied to remove federally imposed cap on Puerto Rico for Medicaid funding. H.R.4939, Emergency Supplemental Appropriations Act of Defense, the Global War on Terror, and Hurricane Recovery of 2006, Lobbied to preserve the market based Medicare Part D Rx drug Benefit. H.R.5704, Access to Medicare Imaging Act, Lobbied for passage of the bill, which would provide for a budget neutral two-year moratorium on Medicare payment reductions for imaging services. H.Con.Res.373, Establishing the congressional budget for the United States Government for fiscal year 2007, Lobbied to preserve the Medicare Part D drug benefit.

H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2006. Lobbied for increased funding for Ryan White program. H.R.5122, National Defense Authorization Act for FY2007, Lobbied to ensure safety and access to prescription drugs. H.Con.Res.376, Establishing the congressional budget for the United States Government for fiscal year 2006, revising appropriate budgetary levels for fiscal year 2005, and setting forth appropriate budgetary levels for fiscal year 2008 through 2011. Lobbied against an amendment to remove language from the MMA prohibiting HHS from interfacing in negotiations for the drug benefit. H.R.5384, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007. Lobbied to ensure safety of prescription drugs.

Lobbied against an amendment to remove language from the MMA prohibiting IHS from interfacing in negotiations for the drug benefit. H.R.5384, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007. Lobbied to ensure safety of prescription drugs. H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2006. Lobbied for increased funding for Ryan White program. H.R.5122, National Defense Authorization Act for FY2007, Lobbied to ensure safety and access to prescription drugs. H.Res.100, Continuing Resolutions for 2007 Appropriations, Lobbied to ensure adequate funding of healthcare programs. H.Con.Res.376, Establishing the congressional budget for the United States Government for fiscal year 2006, revising appropriate budgetary levels for fiscal year 2005, and setting forth appropriate budgetary levels for fiscal year 2008 through 2011.

Lobbied against an amendment to remove language from the MMA prohibiting IHS from interfacing in negotiations for the drug benefit. H.R.5384, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007. Lobbied to ensure safety of prescription drugs. H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2006. Lobbied for increased funding for Ryan White program. H.R.5122, National Defense Authorization Act for FY2007, Lobbied to ensure safety and access to prescription drugs. H.Res.100, Continuing Resolutions for 2007 Appropriations, Lobbied to ensure adequate funding of healthcare programs. H.Con.Res.376, Establishing the congressional budget for the United States Government for fiscal year 2006, revising appropriate budgetary levels for fiscal year 2005, and setting forth appropriate budgetary levels for fiscal year 2008 through 2011.

Lobbied to prevent provisions adverse to prescription drug approval process.H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870, Federal Food, Drug and Cosmetic Act, Lobbied to ensure safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R.4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R.3559, Medicare DME Access Act, Lobbied to ensure access to medical devices and DME services. H.R. 6143, Ryan White Care Act Reauthorization, Lobbied to ensure safe access to prescription drugs. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.2300, Lower Priced Drugs Act of 2006, Lobbied to preserve incentives for R&D for pediatric populations. S.3558, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. S.3650, Helping Fill the Medicare Rx Gap Act, Lobbied to ensure safe access to prescription drugs. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children. S.Res 556, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Res 982, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005.

H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005. Lobbied to prevent provisions adverse to prescription drug approval process. H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870,Federal Food, Drug and Cosmetic Act , Lobbied to ensure the safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R. 4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R. 3559, Medicare DME Access Act, Lobbied to remove certain DME services from competitive bidding, implement quality standards, and passage of the bill. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.3558, The National Hepatitis B Awareness Act of 2006, lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit bran name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children.

Lobbied to prevent provisions adverse to prescription drug approval process.H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870, Federal Food, Drug and Cosmetic Act, Lobbied to ensure safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R.4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R.3559, Medicare DME Access Act, Lobbied to ensure access to medical devices and DME services. H.R. 6143, Ryan White Care Act Reauthorization, Lobbied to ensure safe access to prescription drugs. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.2300, Lower Priced Drugs Act of 2006, Lobbied to preserve incentives for R&D for pediatric populations. S.3558, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. S.3650, Helping Fill the Medicare Rx Gap Act, Lobbied to ensure safe access to prescription drugs. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children. S.Res 556, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Res 982, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005.

S.1307, Central American Free Trade Agreement, Lobbied for equitable treatment of pharmaceutical products. H.R.3025, Central American Free Trade Agreement, Lobbied for equitable treatment of pharmaceutical products.

S.1307, Central American Free Trade Agreement, Lobbied for equitable treatment of pharmaceutical products. H.R. 3045, Central American Free Trade Agreement, Lobbied for equitable treatment of pharmaceutical products.

H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, lobbied for final passage of the bill.

H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, Lobbied for final passage of the bill. H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs.

H.R.4297 Tax Relief Extension Reconciliation Act of 2005, Lobbied to amend the IRS Section 170 definition of income for purposes of charitable deductions. S.1783, R&D Tax Credit, Lobbied to amend the IRS Section 170 definition of income for purposes of charitable tax deductions and to extend the research and development tax credit. H.R.2830R&D Tax Credit, Lobbied to amend the IRS Section 170 definition of income for purposes of charitable tax deductions and to extend the research and development tax credit.

H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, lobbied for final passage of the bill.

H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, Lobbied for final passage of the bill. H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs.

Lobbied to prevent provisions adverse to prescription drug approval process.H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870, Federal Food, Drug and Cosmetic Act, Lobbied to ensure safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R.4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R.3559, Medicare DME Access Act, Lobbied to ensure access to medical devices and DME services. H.R. 6143, Ryan White Care Act Reauthorization, Lobbied to ensure safe access to prescription drugs. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.2300, Lower Priced Drugs Act of 2006, Lobbied to preserve incentives for R&D for pediatric populations. S.3558, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. S.3650, Helping Fill the Medicare Rx Gap Act, Lobbied to ensure safe access to prescription drugs. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children. S.Res 556, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Res 982, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005.

S.2300, Federal Food Drug & Cosmetic Act, Lobbied to preserve exclusivity of innovative prescription drugs. H.R.2795, Patent Act of 2005, Lobbied to ensure strong IP protections for prescriptions drugs. H.R.5672, Science, State, Justice, Commerce, and Related Agencies Appropriations Act, 2007,Lobbied to maintain the ability of the U.S. Trade Representative to negotiate intellectual property issues.

H.R.2795, Patent Act of 2005, Lobbied to ensure strong IP protections for prescriptions drugs. H.R.5672, Science, State, Justice, Commerce, and Related Agencies Appropriations Act, 2007, Lobbied to maintain the ability of the U.S. Trade Representative to negotiate intellectual property issues. S.2300, Federal Food, Drug and Cosmetic Act, Lobbied to preserve the exclusivity of innovative prescription drugs.

Lobbied to prevent provisions adverse to prescription drug approval process.H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870, Federal Food, Drug and Cosmetic Act, Lobbied to ensure safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R.4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R.3559, Medicare DME Access Act, Lobbied to ensure access to medical devices and DME services. H.R. 6143, Ryan White Care Act Reauthorization, Lobbied to ensure safe access to prescription drugs. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.2300, Lower Priced Drugs Act of 2006, Lobbied to preserve incentives for R&D for pediatric populations. S.3558, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. S.3650, Helping Fill the Medicare Rx Gap Act, Lobbied to ensure safe access to prescription drugs. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children. S.Res 556, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Res 982, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005.

H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005. Lobbied to prevent provisions adverse to prescription drug approval process. H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870,Federal Food, Drug and Cosmetic Act , Lobbied to ensure the safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R. 4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R. 3559, Medicare DME Access Act, Lobbied to remove certain DME services from competitive bidding, implement quality standards, and passage of the bill. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.3558, The National Hepatitis B Awareness Act of 2006, lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit bran name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children.

H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005. Lobbied to prevent provisions adverse to prescription drug approval process. H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870,Federal Food, Drug and Cosmetic Act , Lobbied to ensure the safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R. 4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R. 3559, Medicare DME Access Act, Lobbied to remove certain DME services from competitive bidding, implement quality standards, and passage of the bill. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.3558, The National Hepatitis B Awareness Act of 2006, lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit bran name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children.

Lobbied to prevent provisions adverse to prescription drug approval process.H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870, Federal Food, Drug and Cosmetic Act, Lobbied to ensure safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R.4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R.3559, Medicare DME Access Act, Lobbied to ensure access to medical devices and DME services. H.R. 6143, Ryan White Care Act Reauthorization, Lobbied to ensure safe access to prescription drugs. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.2300, Lower Priced Drugs Act of 2006, Lobbied to preserve incentives for R&D for pediatric populations. S.3558, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. S.3650, Helping Fill the Medicare Rx Gap Act, Lobbied to ensure safe access to prescription drugs. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children. S.Res 556, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Res 982, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005.

H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, lobbied for final passage of the bill.

Lobbied to prevent provisions adverse to prescription drug approval process.H.R.5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007, Lobbied for increased funding for AIDS Drug Assistance Program. H.R.328, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.700, Pharmaceutical Market Access Act of 2005, Lobbied to ensure safety of prescription drugs. H.R.870, Federal Food, Drug and Cosmetic Act, Lobbied to ensure safety of prescription drugs. H.R.898, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. H.R.4550, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. H.R.3559, Medicare DME Access Act, Lobbied to ensure access to medical devices and DME services. H.R. 6143, Ryan White Care Act Reauthorization, Lobbied to ensure safe access to prescription drugs. S.1064, Stroke Treatment and Ongoing Prevention Act, Lobbied for passage of the bill. S.2300, Lower Priced Drugs Act of 2006, Lobbied to preserve incentives for R&D for pediatric populations. S.3558, The National Hepatitis B Awareness Act, Lobbied to raise awareness about Hepatitis B and for passage of the bill. S.3582, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, Lobbied to ensure the orderly transition of drugs from "innovation" to "generic" status. S.3650, Helping Fill the Medicare Rx Gap Act, Lobbied to ensure safe access to prescription drugs. WIC (no bill), Lobbied for improved nutrition and funding sources for the Supplemental Feeding Program for Women, Infants, and Children. S.Res 556, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Res 982, Lobbied to raise awareness of P.A.D. and for passage of the bill. H.Con.Res.130, Expressing the sense of the Congress with respect to the awareness, prevention, early detection, and effective treatment of viral hepatitis, and for other purposes. Lobbied for awareness of Hepatitis B. H.R.2090, Food and Drug Administration Improvement Act of 2005.

H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, Lobbied for final passage of the bill. H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs.